Skip to content
Search

Latest Stories

New Medicine Care and Review replaces CMS Regulations 2009

The National Health Service Pharmaceutical Services (Scotland) Regulations 2009 for the Chronic Medication Service (CMS) have been revoked from February 12.

The Regulations 2009 for CMS will be replaced with new regulations for the Medicine Care and Review Service (MCR) including directions and service specification.


The new MCR directions include the addition of care home residents as eligible, which will be rolled out locally by NHS Boards.

Definitions of serial prescribers and serial prescriptions have been amended, with the requirement for a patient to be registered with the pharmacy before serial prescriptions are produced, now removed.

“Registering will help you to get advice and support tailored to you. Pharmacists in the community can't see your GP record, so registering for the service helps them to build a picture of your individual needs and what matters to you when it comes to your health,” the Scottish government said.

Serial prescriptions can now be written for 24, 48 or 56 weeks.

There will be no disruption of service for patients as they transfer from CMS to MCR, although a new MCR patient leaflet which includes care home residents as eligible, should be used to explain the service to patients.

A new Public Health poster campaign for MCR will commence on March 1, and contractors are suggested to retain the poster for future reuse.

Contractor payments for MCR will remain as with CMS until a new model is developed in the next financial year.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less